Research findings indicate that neoantigens have the potential to activate tumour-specific T-cell-mediated anti-tumour immune responses.
Validation of Neoantigen In Silico Prediction using QuickSwitch™ Kits
![Validation of Neoantigen In Silico Prediction using QuickSwitch™ Kits Validation of Neoantigen In Silico Prediction using QuickSwitch™ Kits](https://www.caltagmedsystems.co.uk/information/wp-content/uploads/mbl-nanotech-tetramers-blog-post-image-600x400px-600x300.png)
Research findings indicate that neoantigens have the potential to activate tumour-specific T-cell-mediated anti-tumour immune responses.